Le Lézard
Classified in: Health, Science and technology
Subject: SHA

Change in the number of shares and votes in BioInvent International AB


LUND, Sweden, March 31, 2021 /PRNewswire/ -- BioInvent International AB (publ) (Nasdaq Stockholm: BINV) today announced that the company's total number of shares as per March 31, 2021 amounts to 58,471,096 shares, corresponding to an equal number of votes. The increase in the number of shares and votes results from the directed issue of MSEK 819 to international and Swedish institutional investors by issuance of 16,260,601 shares, announced on February 23, 2021 and approved by the General Meeting on March 23, 2021.

About BioInvent

BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase l/ll trials for the treatment of hematological cancer and solid tumors, respectively. The Company's validated, proprietary F.I.R.S.Ttm technology platform simultaneously identifies both targets and the antibodies that bind to them, generating many promising new drug candidates to fuel the Company's own clinical development pipeline or for additional licensing and partnering.

The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company's fully integrated manufacturing unit. More information is available at www.bioinvent.com.

For further information, please contact:

Cecilia Hofvander

Senior Director Investor Relations

+46 (0)46 286 85 50

[email protected]

BioInvent International AB (publ)

Co. Reg. No.: 556537-7263

Visiting address: Ideongatan 1

Mailing address: 223 70 LUND

Phone: +46 (0)46 286 85 50

www.bioinvent.com

This information is information that BioInvent International AB is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 08:30 a.m. CEST on March 31, 2021.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioinvent-international-ab/r/change-in-the-number-of-shares-and-votes-in-bioinvent-international-ab,c3317329

The following files are available for download:

https://mb.cision.com/Main/583/3317329/1395175.pdf

Change in the number of shares and votes in BioInvent International AB

SOURCE BioInvent International AB


These press releases may also interest you

at 08:40
MAIA Biotechnology, Inc. , a clinical stage company developing telomere-targeting immunotherapies for cancer, announced its participation in the upcoming BIO International Convention taking place June 3-6, 2024, in San Diego, California. The BIO...

at 08:35
Schrödinger, Inc. , whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on May 16, 2024, the company granted restricted stock units (RSUs) with respect to 4,090 shares of...

at 08:34
BioWellnessX is excited to announce its continued expansion into the THCa flower wholesale market with an even broader selection of high-end products available for wholesalers and retail stores nationwide. We are certainly no strangers to the...

at 08:33
Single Pass, Inc., the pioneer and sole provider of disposable electrocautery devices for preventing post-biopsy bleeding, is delighted to announce its strategic partnership with 3comma Medical / 3comma Medical GmbH, a commercial services firm that...

at 08:31
NetSecurity Corporation, a leader in endpoint security solutions, today announced impressive results from independent testing of its ThreatResponder® platform. Conducted by AV-Comparatives, a recognized third-party anti-virus and security software...

at 08:30
Reliq Health Technologies Inc. ("Reliq" or the "Company"), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has expanded a...



News published on and distributed by: